Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness Ruchika Sharma15 Dec 2024 1:15 PM ISTBasel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...
Safety of Lupin's Ranibizumab (Ranieyes) established in Large-Scale Multicenter Study with 2194 injections in 1401 eyes MDTV Bureau6 Dec 2024 12:19 PM ISTReal-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) is a safe...
Intravitreal Aflibercept and Faricimab decreases ocular blood flow to optic nerve head and peripapillary retinal vessels: Study Dr Ishan Kataria18 Nov 2024 8:00 PM ISTDiabetic retinopathy (DR) is the primary cause of visual impairment among working-age populations in industrialized nations. Vision loss may result...
Merck, EyeBio announce initiation of Phase 2b/3 clinical trial for Restoret for Diabetic Macular Edema Ruchika Sharma8 Sept 2024 4:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned subsidiary of Merck & Co., Inc., Rahway,...
Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
New eye drops found safe and effective in diabetic retinopathy and diabetic macular edema in New trial Dr. Kamal Kant Kohli14 March 2024 1:15 AM ISTNew eye drop treatment has been found to be safe and tolerable with 100% participants completing the study for diabetic retinopathy and diabetic...
Roche Pharma India forays into Ophthalmology space with launch of Vabysmo Ruchika Sharma6 March 2024 4:10 PM ISTAs the world's first bispecific antibody, Vabysmo is a single molecule designed to target and inhibit the effects of two targets, providing the...
Conbercept efficacious in short-term treatment of Diabetic Macular Edema with or without Diabetic Nephropathy Dr Riya Dave20 Feb 2024 2:45 PM ISTDiabetic macular edema (DME) is a common complication of diabetes, and when coupled with diabetic nephropathy (DN), it poses additional challenges to...
Bayer Eylea 8 mg gets Japanese marketing nod Ruchika Sharma21 Jan 2024 1:00 PM ISTBerlin: Bayer has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted market authorization for Eylea 8 mg...
Sun Pharma Gets CDSCO Panel Nod for Additional Indication of Ranibizumab solution for injection Dr. Divya Colin16 Jan 2024 6:00 PM ISTNew Delhi: In line with the proposal presented by the drug major Sun Pharma, the Subject Expert Committee (SEC) functional under the Central Drug...
Bayer Eylea 8 mg approved in EU for treatment of two major retinal diseases Ruchika Sharma11 Jan 2024 3:30 PM ISTBerlin: Bayer has announced that the European Commission has granted marketing authorization in the European Union (EU) for new Eylea 8 mg...
Faricimab outperforms anti-VEGF Drugs in DME and AMD Treatment by improving central subfoveal thickness Aditi5 Jan 2024 10:45 PM ISTIn the industrialized world, Neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME) cause blindness. Faricimab, launched...
